Medical Care
Cord Blood Stem Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 549742
- Pages: 125
- Figures: 216
- Views: 2
The global market for Cord Blood Stem Cells was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cord Blood Stem Cells, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cord Blood Stem Cells by region & country, by Type, and by Application.
The Cord Blood Stem Cells market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cord Blood Stem Cells.
Market Segmentation
By Company
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
Segment by Type:
Allogeneic Stem Cell
Autologous Stem Cell
Segment by Application
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cord Blood Stem Cells manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cord Blood Stem Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cord Blood Stem Cells in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cord Blood Stem Cells, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cord Blood Stem Cells by region & country, by Type, and by Application.
The Cord Blood Stem Cells market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cord Blood Stem Cells.
Market Segmentation
By Company
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
Segment by Type:
Allogeneic Stem Cell
Autologous Stem Cell
Segment by Application
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cord Blood Stem Cells manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cord Blood Stem Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cord Blood Stem Cells in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Cord Blood Stem Cells Product Introduction
1.2 Global Cord Blood Stem Cells Market Size Forecast
1.3 Cord Blood Stem Cells Market Trends & Drivers
1.3.1 Cord Blood Stem Cells Industry Trends
1.3.2 Cord Blood Stem Cells Market Drivers & Opportunity
1.3.3 Cord Blood Stem Cells Market Challenges
1.3.4 Cord Blood Stem Cells Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cord Blood Stem Cells Players Revenue Ranking (2023)
2.2 Global Cord Blood Stem Cells Revenue by Company (2019-2024)
2.3 Key Companies Cord Blood Stem Cells Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cord Blood Stem Cells Product Offered
2.5 Key Companies Time to Begin Mass Production of Cord Blood Stem Cells
2.6 Cord Blood Stem Cells Market Competitive Analysis
2.6.1 Cord Blood Stem Cells Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cord Blood Stem Cells Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cord Blood Stem Cells as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Allogeneic Stem Cell
3.1.2 Autologous Stem Cell
3.2 Global Cord Blood Stem Cells Sales Value by Type
3.2.1 Global Cord Blood Stem Cells Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cord Blood Stem Cells Sales Value, by Type (2019-2030)
3.2.3 Global Cord Blood Stem Cells Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Autoimmune Diseases
4.1.2 Immunodeficiencies
4.1.3 Malignancies,Caners
4.1.4 Solid Tumors
4.1.5 Others
4.2 Global Cord Blood Stem Cells Sales Value by Application
4.2.1 Global Cord Blood Stem Cells Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cord Blood Stem Cells Sales Value, by Application (2019-2030)
4.2.3 Global Cord Blood Stem Cells Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cord Blood Stem Cells Sales Value by Region
5.1.1 Global Cord Blood Stem Cells Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cord Blood Stem Cells Sales Value by Region (2019-2024)
5.1.3 Global Cord Blood Stem Cells Sales Value by Region (2025-2030)
5.1.4 Global Cord Blood Stem Cells Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cord Blood Stem Cells Sales Value, 2019-2030
5.2.2 North America Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cord Blood Stem Cells Sales Value, 2019-2030
5.3.2 Europe Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cord Blood Stem Cells Sales Value, 2019-2030
5.4.2 Asia Pacific Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cord Blood Stem Cells Sales Value, 2019-2030
5.5.2 South America Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cord Blood Stem Cells Sales Value, 2019-2030
5.6.2 Middle East & Africa Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cord Blood Stem Cells Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cord Blood Stem Cells Sales Value
6.3 United States
6.3.1 United States Cord Blood Stem Cells Sales Value, 2019-2030
6.3.2 United States Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cord Blood Stem Cells Sales Value, 2019-2030
6.4.2 Europe Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cord Blood Stem Cells Sales Value, 2019-2030
6.5.2 China Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cord Blood Stem Cells Sales Value, 2019-2030
6.6.2 Japan Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cord Blood Stem Cells Sales Value, 2019-2030
6.7.2 South Korea Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cord Blood Stem Cells Sales Value, 2019-2030
6.8.2 Southeast Asia Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cord Blood Stem Cells Sales Value, 2019-2030
6.9.2 India Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Advanced Cell Technology
7.1.1 Advanced Cell Technology Profile
7.1.2 Advanced Cell Technology Main Business
7.1.3 Advanced Cell Technology Cord Blood Stem Cells Products, Services and Solutions
7.1.4 Advanced Cell Technology Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.1.5 Advanced Cell Technology Recent Developments
7.2 California Stem Cell
7.2.1 California Stem Cell Profile
7.2.2 California Stem Cell Main Business
7.2.3 California Stem Cell Cord Blood Stem Cells Products, Services and Solutions
7.2.4 California Stem Cell Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.2.5 California Stem Cell Recent Developments
7.3 Cytori Therapeutics
7.3.1 Cytori Therapeutics Profile
7.3.2 Cytori Therapeutics Main Business
7.3.3 Cytori Therapeutics Cord Blood Stem Cells Products, Services and Solutions
7.3.4 Cytori Therapeutics Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.3.5 Mesoblast Limited Recent Developments
7.4 Mesoblast Limited
7.4.1 Mesoblast Limited Profile
7.4.2 Mesoblast Limited Main Business
7.4.3 Mesoblast Limited Cord Blood Stem Cells Products, Services and Solutions
7.4.4 Mesoblast Limited Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.4.5 Mesoblast Limited Recent Developments
7.5 Opexa Therapeutics Inc.
7.5.1 Opexa Therapeutics Inc. Profile
7.5.2 Opexa Therapeutics Inc. Main Business
7.5.3 Opexa Therapeutics Inc. Cord Blood Stem Cells Products, Services and Solutions
7.5.4 Opexa Therapeutics Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.5.5 Opexa Therapeutics Inc. Recent Developments
7.6 Athersys Inc.
7.6.1 Athersys Inc. Profile
7.6.2 Athersys Inc. Main Business
7.6.3 Athersys Inc. Cord Blood Stem Cells Products, Services and Solutions
7.6.4 Athersys Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.6.5 Athersys Inc. Recent Developments
7.7 Geron Corporation
7.7.1 Geron Corporation Profile
7.7.2 Geron Corporation Main Business
7.7.3 Geron Corporation Cord Blood Stem Cells Products, Services and Solutions
7.7.4 Geron Corporation Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.7.5 Geron Corporation Recent Developments
7.8 Neostem Inc.
7.8.1 Neostem Inc. Profile
7.8.2 Neostem Inc. Main Business
7.8.3 Neostem Inc. Cord Blood Stem Cells Products, Services and Solutions
7.8.4 Neostem Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.8.5 Neostem Inc. Recent Developments
7.9 CBR Systems, Inc.
7.9.1 CBR Systems, Inc. Profile
7.9.2 CBR Systems, Inc. Main Business
7.9.3 CBR Systems, Inc. Cord Blood Stem Cells Products, Services and Solutions
7.9.4 CBR Systems, Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.9.5 CBR Systems, Inc. Recent Developments
7.10 Cordlife
7.10.1 Cordlife Profile
7.10.2 Cordlife Main Business
7.10.3 Cordlife Cord Blood Stem Cells Products, Services and Solutions
7.10.4 Cordlife Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.10.5 Cordlife Recent Developments
7.11 Cryo-Cell
7.11.1 Cryo-Cell Profile
7.11.2 Cryo-Cell Main Business
7.11.3 Cryo-Cell Cord Blood Stem Cells Products, Services and Solutions
7.11.4 Cryo-Cell Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.11.5 Cryo-Cell Recent Developments
7.12 Cryo-Save AG (A Group of Esperite)
7.12.1 Cryo-Save AG (A Group of Esperite) Profile
7.12.2 Cryo-Save AG (A Group of Esperite) Main Business
7.12.3 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Products, Services and Solutions
7.12.4 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.12.5 Cryo-Save AG (A Group of Esperite) Recent Developments
7.13 Lifecell
7.13.1 Lifecell Profile
7.13.2 Lifecell Main Business
7.13.3 Lifecell Cord Blood Stem Cells Products, Services and Solutions
7.13.4 Lifecell Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.13.5 Lifecell Recent Developments
7.14 Stemcyte
7.14.1 Stemcyte Profile
7.14.2 Stemcyte Main Business
7.14.3 Stemcyte Cord Blood Stem Cells Products, Services and Solutions
7.14.4 Stemcyte Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.14.5 Stemcyte Recent Developments
7.15 Viacord
7.15.1 Viacord Profile
7.15.2 Viacord Main Business
7.15.3 Viacord Cord Blood Stem Cells Products, Services and Solutions
7.15.4 Viacord Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.15.5 Viacord Recent Developments
7.16 Smart Cells International Ltd.
7.16.1 Smart Cells International Ltd. Profile
7.16.2 Smart Cells International Ltd. Main Business
7.16.3 Smart Cells International Ltd. Cord Blood Stem Cells Products, Services and Solutions
7.16.4 Smart Cells International Ltd. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.16.5 Smart Cells International Ltd. Recent Developments
7.17 Cryoviva India
7.17.1 Cryoviva India Profile
7.17.2 Cryoviva India Main Business
7.17.3 Cryoviva India Cord Blood Stem Cells Products, Services and Solutions
7.17.4 Cryoviva India Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.17.5 Cryoviva India Recent Developments
7.18 Cordvida
7.18.1 Cordvida Profile
7.18.2 Cordvida Main Business
7.18.3 Cordvida Cord Blood Stem Cells Products, Services and Solutions
7.18.4 Cordvida Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.18.5 Cordvida Recent Developments
7.19 China Cord Blood Corporation
7.19.1 China Cord Blood Corporation Profile
7.19.2 China Cord Blood Corporation Main Business
7.19.3 China Cord Blood Corporation Cord Blood Stem Cells Products, Services and Solutions
7.19.4 China Cord Blood Corporation Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.19.5 China Cord Blood Corporation Recent Developments
8 Industry Chain Analysis
8.1 Cord Blood Stem Cells Industrial Chain
8.2 Cord Blood Stem Cells Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cord Blood Stem Cells Sales Model
8.5.2 Sales Channel
8.5.3 Cord Blood Stem Cells Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Cord Blood Stem Cells Product Introduction
1.2 Global Cord Blood Stem Cells Market Size Forecast
1.3 Cord Blood Stem Cells Market Trends & Drivers
1.3.1 Cord Blood Stem Cells Industry Trends
1.3.2 Cord Blood Stem Cells Market Drivers & Opportunity
1.3.3 Cord Blood Stem Cells Market Challenges
1.3.4 Cord Blood Stem Cells Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cord Blood Stem Cells Players Revenue Ranking (2023)
2.2 Global Cord Blood Stem Cells Revenue by Company (2019-2024)
2.3 Key Companies Cord Blood Stem Cells Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cord Blood Stem Cells Product Offered
2.5 Key Companies Time to Begin Mass Production of Cord Blood Stem Cells
2.6 Cord Blood Stem Cells Market Competitive Analysis
2.6.1 Cord Blood Stem Cells Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cord Blood Stem Cells Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cord Blood Stem Cells as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Allogeneic Stem Cell
3.1.2 Autologous Stem Cell
3.2 Global Cord Blood Stem Cells Sales Value by Type
3.2.1 Global Cord Blood Stem Cells Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cord Blood Stem Cells Sales Value, by Type (2019-2030)
3.2.3 Global Cord Blood Stem Cells Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Autoimmune Diseases
4.1.2 Immunodeficiencies
4.1.3 Malignancies,Caners
4.1.4 Solid Tumors
4.1.5 Others
4.2 Global Cord Blood Stem Cells Sales Value by Application
4.2.1 Global Cord Blood Stem Cells Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cord Blood Stem Cells Sales Value, by Application (2019-2030)
4.2.3 Global Cord Blood Stem Cells Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cord Blood Stem Cells Sales Value by Region
5.1.1 Global Cord Blood Stem Cells Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cord Blood Stem Cells Sales Value by Region (2019-2024)
5.1.3 Global Cord Blood Stem Cells Sales Value by Region (2025-2030)
5.1.4 Global Cord Blood Stem Cells Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cord Blood Stem Cells Sales Value, 2019-2030
5.2.2 North America Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cord Blood Stem Cells Sales Value, 2019-2030
5.3.2 Europe Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cord Blood Stem Cells Sales Value, 2019-2030
5.4.2 Asia Pacific Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cord Blood Stem Cells Sales Value, 2019-2030
5.5.2 South America Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cord Blood Stem Cells Sales Value, 2019-2030
5.6.2 Middle East & Africa Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cord Blood Stem Cells Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cord Blood Stem Cells Sales Value
6.3 United States
6.3.1 United States Cord Blood Stem Cells Sales Value, 2019-2030
6.3.2 United States Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cord Blood Stem Cells Sales Value, 2019-2030
6.4.2 Europe Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cord Blood Stem Cells Sales Value, 2019-2030
6.5.2 China Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cord Blood Stem Cells Sales Value, 2019-2030
6.6.2 Japan Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cord Blood Stem Cells Sales Value, 2019-2030
6.7.2 South Korea Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cord Blood Stem Cells Sales Value, 2019-2030
6.8.2 Southeast Asia Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cord Blood Stem Cells Sales Value, 2019-2030
6.9.2 India Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Advanced Cell Technology
7.1.1 Advanced Cell Technology Profile
7.1.2 Advanced Cell Technology Main Business
7.1.3 Advanced Cell Technology Cord Blood Stem Cells Products, Services and Solutions
7.1.4 Advanced Cell Technology Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.1.5 Advanced Cell Technology Recent Developments
7.2 California Stem Cell
7.2.1 California Stem Cell Profile
7.2.2 California Stem Cell Main Business
7.2.3 California Stem Cell Cord Blood Stem Cells Products, Services and Solutions
7.2.4 California Stem Cell Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.2.5 California Stem Cell Recent Developments
7.3 Cytori Therapeutics
7.3.1 Cytori Therapeutics Profile
7.3.2 Cytori Therapeutics Main Business
7.3.3 Cytori Therapeutics Cord Blood Stem Cells Products, Services and Solutions
7.3.4 Cytori Therapeutics Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.3.5 Mesoblast Limited Recent Developments
7.4 Mesoblast Limited
7.4.1 Mesoblast Limited Profile
7.4.2 Mesoblast Limited Main Business
7.4.3 Mesoblast Limited Cord Blood Stem Cells Products, Services and Solutions
7.4.4 Mesoblast Limited Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.4.5 Mesoblast Limited Recent Developments
7.5 Opexa Therapeutics Inc.
7.5.1 Opexa Therapeutics Inc. Profile
7.5.2 Opexa Therapeutics Inc. Main Business
7.5.3 Opexa Therapeutics Inc. Cord Blood Stem Cells Products, Services and Solutions
7.5.4 Opexa Therapeutics Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.5.5 Opexa Therapeutics Inc. Recent Developments
7.6 Athersys Inc.
7.6.1 Athersys Inc. Profile
7.6.2 Athersys Inc. Main Business
7.6.3 Athersys Inc. Cord Blood Stem Cells Products, Services and Solutions
7.6.4 Athersys Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.6.5 Athersys Inc. Recent Developments
7.7 Geron Corporation
7.7.1 Geron Corporation Profile
7.7.2 Geron Corporation Main Business
7.7.3 Geron Corporation Cord Blood Stem Cells Products, Services and Solutions
7.7.4 Geron Corporation Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.7.5 Geron Corporation Recent Developments
7.8 Neostem Inc.
7.8.1 Neostem Inc. Profile
7.8.2 Neostem Inc. Main Business
7.8.3 Neostem Inc. Cord Blood Stem Cells Products, Services and Solutions
7.8.4 Neostem Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.8.5 Neostem Inc. Recent Developments
7.9 CBR Systems, Inc.
7.9.1 CBR Systems, Inc. Profile
7.9.2 CBR Systems, Inc. Main Business
7.9.3 CBR Systems, Inc. Cord Blood Stem Cells Products, Services and Solutions
7.9.4 CBR Systems, Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.9.5 CBR Systems, Inc. Recent Developments
7.10 Cordlife
7.10.1 Cordlife Profile
7.10.2 Cordlife Main Business
7.10.3 Cordlife Cord Blood Stem Cells Products, Services and Solutions
7.10.4 Cordlife Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.10.5 Cordlife Recent Developments
7.11 Cryo-Cell
7.11.1 Cryo-Cell Profile
7.11.2 Cryo-Cell Main Business
7.11.3 Cryo-Cell Cord Blood Stem Cells Products, Services and Solutions
7.11.4 Cryo-Cell Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.11.5 Cryo-Cell Recent Developments
7.12 Cryo-Save AG (A Group of Esperite)
7.12.1 Cryo-Save AG (A Group of Esperite) Profile
7.12.2 Cryo-Save AG (A Group of Esperite) Main Business
7.12.3 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Products, Services and Solutions
7.12.4 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.12.5 Cryo-Save AG (A Group of Esperite) Recent Developments
7.13 Lifecell
7.13.1 Lifecell Profile
7.13.2 Lifecell Main Business
7.13.3 Lifecell Cord Blood Stem Cells Products, Services and Solutions
7.13.4 Lifecell Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.13.5 Lifecell Recent Developments
7.14 Stemcyte
7.14.1 Stemcyte Profile
7.14.2 Stemcyte Main Business
7.14.3 Stemcyte Cord Blood Stem Cells Products, Services and Solutions
7.14.4 Stemcyte Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.14.5 Stemcyte Recent Developments
7.15 Viacord
7.15.1 Viacord Profile
7.15.2 Viacord Main Business
7.15.3 Viacord Cord Blood Stem Cells Products, Services and Solutions
7.15.4 Viacord Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.15.5 Viacord Recent Developments
7.16 Smart Cells International Ltd.
7.16.1 Smart Cells International Ltd. Profile
7.16.2 Smart Cells International Ltd. Main Business
7.16.3 Smart Cells International Ltd. Cord Blood Stem Cells Products, Services and Solutions
7.16.4 Smart Cells International Ltd. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.16.5 Smart Cells International Ltd. Recent Developments
7.17 Cryoviva India
7.17.1 Cryoviva India Profile
7.17.2 Cryoviva India Main Business
7.17.3 Cryoviva India Cord Blood Stem Cells Products, Services and Solutions
7.17.4 Cryoviva India Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.17.5 Cryoviva India Recent Developments
7.18 Cordvida
7.18.1 Cordvida Profile
7.18.2 Cordvida Main Business
7.18.3 Cordvida Cord Blood Stem Cells Products, Services and Solutions
7.18.4 Cordvida Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.18.5 Cordvida Recent Developments
7.19 China Cord Blood Corporation
7.19.1 China Cord Blood Corporation Profile
7.19.2 China Cord Blood Corporation Main Business
7.19.3 China Cord Blood Corporation Cord Blood Stem Cells Products, Services and Solutions
7.19.4 China Cord Blood Corporation Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.19.5 China Cord Blood Corporation Recent Developments
8 Industry Chain Analysis
8.1 Cord Blood Stem Cells Industrial Chain
8.2 Cord Blood Stem Cells Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cord Blood Stem Cells Sales Model
8.5.2 Sales Channel
8.5.3 Cord Blood Stem Cells Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Cord Blood Stem Cells Market Trends
Table 2. Cord Blood Stem Cells Market Drivers & Opportunity
Table 3. Cord Blood Stem Cells Market Challenges
Table 4. Cord Blood Stem Cells Market Restraints
Table 5. Global Cord Blood Stem Cells Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cord Blood Stem Cells Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cord Blood Stem Cells Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cord Blood Stem Cells Product Type
Table 9. Key Companies Time to Begin Mass Production of Cord Blood Stem Cells
Table 10. Global Cord Blood Stem Cells Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cord Blood Stem Cells as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cord Blood Stem Cells Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cord Blood Stem Cells Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cord Blood Stem Cells Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cord Blood Stem Cells Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cord Blood Stem Cells Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cord Blood Stem Cells Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cord Blood Stem Cells Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cord Blood Stem Cells Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cord Blood Stem Cells Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cord Blood Stem Cells Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cord Blood Stem Cells Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cord Blood Stem Cells Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cord Blood Stem Cells Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cord Blood Stem Cells Sales Value by Region (2019-2024) & (%)
Table 27. Global Cord Blood Stem Cells Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cord Blood Stem Cells Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cord Blood Stem Cells Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cord Blood Stem Cells Sales Value, (2025-2030) & (US$ Million)
Table 31. Advanced Cell Technology Basic Information List
Table 32. Advanced Cell Technology Description and Business Overview
Table 33. Advanced Cell Technology Cord Blood Stem Cells Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cord Blood Stem Cells Business of Advanced Cell Technology (2019-2024)
Table 35. Advanced Cell Technology Recent Developments
Table 36. California Stem Cell Basic Information List
Table 37. California Stem Cell Description and Business Overview
Table 38. California Stem Cell Cord Blood Stem Cells Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cord Blood Stem Cells Business of California Stem Cell (2019-2024)
Table 40. California Stem Cell Recent Developments
Table 41. Cytori Therapeutics Basic Information List
Table 42. Cytori Therapeutics Description and Business Overview
Table 43. Cytori Therapeutics Cord Blood Stem Cells Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cytori Therapeutics (2019-2024)
Table 45. Cytori Therapeutics Recent Developments
Table 46. Mesoblast Limited Basic Information List
Table 47. Mesoblast Limited Description and Business Overview
Table 48. Mesoblast Limited Cord Blood Stem Cells Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cord Blood Stem Cells Business of Mesoblast Limited (2019-2024)
Table 50. Mesoblast Limited Recent Developments
Table 51. Opexa Therapeutics Inc. Basic Information List
Table 52. Opexa Therapeutics Inc. Description and Business Overview
Table 53. Opexa Therapeutics Inc. Cord Blood Stem Cells Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cord Blood Stem Cells Business of Opexa Therapeutics Inc. (2019-2024)
Table 55. Opexa Therapeutics Inc. Recent Developments
Table 56. Athersys Inc. Basic Information List
Table 57. Athersys Inc. Description and Business Overview
Table 58. Athersys Inc. Cord Blood Stem Cells Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cord Blood Stem Cells Business of Athersys Inc. (2019-2024)
Table 60. Athersys Inc. Recent Developments
Table 61. Geron Corporation Basic Information List
Table 62. Geron Corporation Description and Business Overview
Table 63. Geron Corporation Cord Blood Stem Cells Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cord Blood Stem Cells Business of Geron Corporation (2019-2024)
Table 65. Geron Corporation Recent Developments
Table 66. Neostem Inc. Basic Information List
Table 67. Neostem Inc. Description and Business Overview
Table 68. Neostem Inc. Cord Blood Stem Cells Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cord Blood Stem Cells Business of Neostem Inc. (2019-2024)
Table 70. Neostem Inc. Recent Developments
Table 71. CBR Systems, Inc. Basic Information List
Table 72. CBR Systems, Inc. Description and Business Overview
Table 73. CBR Systems, Inc. Cord Blood Stem Cells Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cord Blood Stem Cells Business of CBR Systems, Inc. (2019-2024)
Table 75. CBR Systems, Inc. Recent Developments
Table 76. Cordlife Basic Information List
Table 77. Cordlife Description and Business Overview
Table 78. Cordlife Cord Blood Stem Cells Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cordlife (2019-2024)
Table 80. Cordlife Recent Developments
Table 81. Cryo-Cell Basic Information List
Table 82. Cryo-Cell Description and Business Overview
Table 83. Cryo-Cell Cord Blood Stem Cells Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cryo-Cell (2019-2024)
Table 85. Cryo-Cell Recent Developments
Table 86. Cryo-Save AG (A Group of Esperite) Basic Information List
Table 87. Cryo-Save AG (A Group of Esperite) Description and Business Overview
Table 88. Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cryo-Save AG (A Group of Esperite) (2019-2024)
Table 90. Cryo-Save AG (A Group of Esperite) Recent Developments
Table 91. Lifecell Basic Information List
Table 92. Lifecell Description and Business Overview
Table 93. Lifecell Cord Blood Stem Cells Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cord Blood Stem Cells Business of Lifecell (2019-2024)
Table 95. Lifecell Recent Developments
Table 96. Stemcyte Basic Information List
Table 97. Stemcyte Description and Business Overview
Table 98. Stemcyte Cord Blood Stem Cells Products, Services and Solutions
Table 99. Revenue (US$ Million) in Cord Blood Stem Cells Business of Stemcyte (2019-2024)
Table 100. Stemcyte Recent Developments
Table 101. Viacord Basic Information List
Table 102. Viacord Description and Business Overview
Table 103. Viacord Cord Blood Stem Cells Products, Services and Solutions
Table 104. Revenue (US$ Million) in Cord Blood Stem Cells Business of Viacord (2019-2024)
Table 105. Viacord Recent Developments
Table 106. Smart Cells International Ltd. Basic Information List
Table 107. Smart Cells International Ltd. Description and Business Overview
Table 108. Smart Cells International Ltd. Cord Blood Stem Cells Products, Services and Solutions
Table 109. Revenue (US$ Million) in Cord Blood Stem Cells Business of Smart Cells International Ltd. (2019-2024)
Table 110. Smart Cells International Ltd. Recent Developments
Table 111. Cryoviva India Basic Information List
Table 112. Cryoviva India Description and Business Overview
Table 113. Cryoviva India Cord Blood Stem Cells Products, Services and Solutions
Table 114. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cryoviva India (2019-2024)
Table 115. Cryoviva India Recent Developments
Table 116. Cordvida Basic Information List
Table 117. Cordvida Description and Business Overview
Table 118. Cordvida Cord Blood Stem Cells Products, Services and Solutions
Table 119. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cordvida (2019-2024)
Table 120. Cordvida Recent Developments
Table 121. China Cord Blood Corporation Basic Information List
Table 122. China Cord Blood Corporation Description and Business Overview
Table 123. China Cord Blood Corporation Cord Blood Stem Cells Products, Services and Solutions
Table 124. Revenue (US$ Million) in Cord Blood Stem Cells Business of China Cord Blood Corporation (2019-2024)
Table 125. China Cord Blood Corporation Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Cord Blood Stem Cells Downstream Customers
Table 129. Cord Blood Stem Cells Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cord Blood Stem Cells Product Picture
Figure 2. Global Cord Blood Stem Cells Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 4. Cord Blood Stem Cells Report Years Considered
Figure 5. Global Cord Blood Stem Cells Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cord Blood Stem Cells Revenue in 2023
Figure 7. Cord Blood Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Allogeneic Stem Cell Picture
Figure 9. Autologous Stem Cell Picture
Figure 10. Global Cord Blood Stem Cells Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Cord Blood Stem Cells Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Autoimmune Diseases
Figure 13. Product Picture of Immunodeficiencies
Figure 14. Product Picture of Malignancies,Caners
Figure 15. Product Picture of Solid Tumors
Figure 16. Product Picture of Others
Figure 17. Global Cord Blood Stem Cells Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Cord Blood Stem Cells Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Cord Blood Stem Cells Sales Value (%), (2019-2030)
Figure 30. United States Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 36. China Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 38. China Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 48. India Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 50. India Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 51. Cord Blood Stem Cells Industrial Chain
Figure 52. Cord Blood Stem Cells Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Table 1. Cord Blood Stem Cells Market Trends
Table 2. Cord Blood Stem Cells Market Drivers & Opportunity
Table 3. Cord Blood Stem Cells Market Challenges
Table 4. Cord Blood Stem Cells Market Restraints
Table 5. Global Cord Blood Stem Cells Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cord Blood Stem Cells Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cord Blood Stem Cells Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cord Blood Stem Cells Product Type
Table 9. Key Companies Time to Begin Mass Production of Cord Blood Stem Cells
Table 10. Global Cord Blood Stem Cells Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cord Blood Stem Cells as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cord Blood Stem Cells Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cord Blood Stem Cells Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cord Blood Stem Cells Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cord Blood Stem Cells Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cord Blood Stem Cells Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cord Blood Stem Cells Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cord Blood Stem Cells Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cord Blood Stem Cells Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cord Blood Stem Cells Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cord Blood Stem Cells Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cord Blood Stem Cells Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cord Blood Stem Cells Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cord Blood Stem Cells Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cord Blood Stem Cells Sales Value by Region (2019-2024) & (%)
Table 27. Global Cord Blood Stem Cells Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cord Blood Stem Cells Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cord Blood Stem Cells Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cord Blood Stem Cells Sales Value, (2025-2030) & (US$ Million)
Table 31. Advanced Cell Technology Basic Information List
Table 32. Advanced Cell Technology Description and Business Overview
Table 33. Advanced Cell Technology Cord Blood Stem Cells Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cord Blood Stem Cells Business of Advanced Cell Technology (2019-2024)
Table 35. Advanced Cell Technology Recent Developments
Table 36. California Stem Cell Basic Information List
Table 37. California Stem Cell Description and Business Overview
Table 38. California Stem Cell Cord Blood Stem Cells Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cord Blood Stem Cells Business of California Stem Cell (2019-2024)
Table 40. California Stem Cell Recent Developments
Table 41. Cytori Therapeutics Basic Information List
Table 42. Cytori Therapeutics Description and Business Overview
Table 43. Cytori Therapeutics Cord Blood Stem Cells Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cytori Therapeutics (2019-2024)
Table 45. Cytori Therapeutics Recent Developments
Table 46. Mesoblast Limited Basic Information List
Table 47. Mesoblast Limited Description and Business Overview
Table 48. Mesoblast Limited Cord Blood Stem Cells Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cord Blood Stem Cells Business of Mesoblast Limited (2019-2024)
Table 50. Mesoblast Limited Recent Developments
Table 51. Opexa Therapeutics Inc. Basic Information List
Table 52. Opexa Therapeutics Inc. Description and Business Overview
Table 53. Opexa Therapeutics Inc. Cord Blood Stem Cells Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cord Blood Stem Cells Business of Opexa Therapeutics Inc. (2019-2024)
Table 55. Opexa Therapeutics Inc. Recent Developments
Table 56. Athersys Inc. Basic Information List
Table 57. Athersys Inc. Description and Business Overview
Table 58. Athersys Inc. Cord Blood Stem Cells Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cord Blood Stem Cells Business of Athersys Inc. (2019-2024)
Table 60. Athersys Inc. Recent Developments
Table 61. Geron Corporation Basic Information List
Table 62. Geron Corporation Description and Business Overview
Table 63. Geron Corporation Cord Blood Stem Cells Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cord Blood Stem Cells Business of Geron Corporation (2019-2024)
Table 65. Geron Corporation Recent Developments
Table 66. Neostem Inc. Basic Information List
Table 67. Neostem Inc. Description and Business Overview
Table 68. Neostem Inc. Cord Blood Stem Cells Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cord Blood Stem Cells Business of Neostem Inc. (2019-2024)
Table 70. Neostem Inc. Recent Developments
Table 71. CBR Systems, Inc. Basic Information List
Table 72. CBR Systems, Inc. Description and Business Overview
Table 73. CBR Systems, Inc. Cord Blood Stem Cells Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cord Blood Stem Cells Business of CBR Systems, Inc. (2019-2024)
Table 75. CBR Systems, Inc. Recent Developments
Table 76. Cordlife Basic Information List
Table 77. Cordlife Description and Business Overview
Table 78. Cordlife Cord Blood Stem Cells Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cordlife (2019-2024)
Table 80. Cordlife Recent Developments
Table 81. Cryo-Cell Basic Information List
Table 82. Cryo-Cell Description and Business Overview
Table 83. Cryo-Cell Cord Blood Stem Cells Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cryo-Cell (2019-2024)
Table 85. Cryo-Cell Recent Developments
Table 86. Cryo-Save AG (A Group of Esperite) Basic Information List
Table 87. Cryo-Save AG (A Group of Esperite) Description and Business Overview
Table 88. Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cryo-Save AG (A Group of Esperite) (2019-2024)
Table 90. Cryo-Save AG (A Group of Esperite) Recent Developments
Table 91. Lifecell Basic Information List
Table 92. Lifecell Description and Business Overview
Table 93. Lifecell Cord Blood Stem Cells Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cord Blood Stem Cells Business of Lifecell (2019-2024)
Table 95. Lifecell Recent Developments
Table 96. Stemcyte Basic Information List
Table 97. Stemcyte Description and Business Overview
Table 98. Stemcyte Cord Blood Stem Cells Products, Services and Solutions
Table 99. Revenue (US$ Million) in Cord Blood Stem Cells Business of Stemcyte (2019-2024)
Table 100. Stemcyte Recent Developments
Table 101. Viacord Basic Information List
Table 102. Viacord Description and Business Overview
Table 103. Viacord Cord Blood Stem Cells Products, Services and Solutions
Table 104. Revenue (US$ Million) in Cord Blood Stem Cells Business of Viacord (2019-2024)
Table 105. Viacord Recent Developments
Table 106. Smart Cells International Ltd. Basic Information List
Table 107. Smart Cells International Ltd. Description and Business Overview
Table 108. Smart Cells International Ltd. Cord Blood Stem Cells Products, Services and Solutions
Table 109. Revenue (US$ Million) in Cord Blood Stem Cells Business of Smart Cells International Ltd. (2019-2024)
Table 110. Smart Cells International Ltd. Recent Developments
Table 111. Cryoviva India Basic Information List
Table 112. Cryoviva India Description and Business Overview
Table 113. Cryoviva India Cord Blood Stem Cells Products, Services and Solutions
Table 114. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cryoviva India (2019-2024)
Table 115. Cryoviva India Recent Developments
Table 116. Cordvida Basic Information List
Table 117. Cordvida Description and Business Overview
Table 118. Cordvida Cord Blood Stem Cells Products, Services and Solutions
Table 119. Revenue (US$ Million) in Cord Blood Stem Cells Business of Cordvida (2019-2024)
Table 120. Cordvida Recent Developments
Table 121. China Cord Blood Corporation Basic Information List
Table 122. China Cord Blood Corporation Description and Business Overview
Table 123. China Cord Blood Corporation Cord Blood Stem Cells Products, Services and Solutions
Table 124. Revenue (US$ Million) in Cord Blood Stem Cells Business of China Cord Blood Corporation (2019-2024)
Table 125. China Cord Blood Corporation Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Cord Blood Stem Cells Downstream Customers
Table 129. Cord Blood Stem Cells Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cord Blood Stem Cells Product Picture
Figure 2. Global Cord Blood Stem Cells Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 4. Cord Blood Stem Cells Report Years Considered
Figure 5. Global Cord Blood Stem Cells Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cord Blood Stem Cells Revenue in 2023
Figure 7. Cord Blood Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Allogeneic Stem Cell Picture
Figure 9. Autologous Stem Cell Picture
Figure 10. Global Cord Blood Stem Cells Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Cord Blood Stem Cells Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Autoimmune Diseases
Figure 13. Product Picture of Immunodeficiencies
Figure 14. Product Picture of Malignancies,Caners
Figure 15. Product Picture of Solid Tumors
Figure 16. Product Picture of Others
Figure 17. Global Cord Blood Stem Cells Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Cord Blood Stem Cells Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Cord Blood Stem Cells Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Cord Blood Stem Cells Sales Value (%), (2019-2030)
Figure 30. United States Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 36. China Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 38. China Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 48. India Cord Blood Stem Cells Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
Figure 50. India Cord Blood Stem Cells Sales Value by Application (%), 2023 VS 2030
Figure 51. Cord Blood Stem Cells Industrial Chain
Figure 52. Cord Blood Stem Cells Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232